Altimmune, Inc.
ALT
$7.03
$0.253.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.75% | 26.74% | -10.52% | -53.42% | -21.52% |
| Total Depreciation and Amortization | -72.90% | -71.05% | 106.70% | 112.08% | -14.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.89% | -82.94% | -22.93% | 24.06% | 22.93% |
| Change in Net Operating Assets | -111.57% | 200.12% | -224.39% | 157.50% | 421.60% |
| Cash from Operations | -2.95% | -10.48% | -32.37% | 6.58% | 15.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.09% | 271.28% | -72.76% | -192.79% | -395.97% |
| Cash from Investing | 87.09% | 271.28% | -72.76% | -192.70% | -397.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10,201.47% | -86.14% | -54.24% | -98.52% | 72.96% |
| Repurchase of Common Stock | -13.00% | 94.59% | -100.00% | 51.20% | -23.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13,172.41% | -86.14% | -54.76% | -100.35% | 13.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.69% | -88.70% | -65.54% | -837.37% | -776.21% |